Abstract:

Vitamin D is a fat-soluble vitamin that plays a role in the metabolism of calcium and phosphorus. Deep vein thrombosis (DVT) is a major health problem worldwide. Some researchers have that vitamin D supplements reduce the risk of venous thrombembolism. The aim of our study is to evaluate the level of vitamin D in patients with DVT. Method and Requirements: This study was conducted between December 2015-December 2018. Patients with vitamin D levels measured in December, January, February and March were taken into the study scope. The levels of serum D 25 (OH) D (25 hydroxyvitamin) were measured to assess the levels of vitamin D in patients. STUDY: Our study includes 58 patients with vitamin D levels measured and diagnosed with DVT. 27 of the patients were female and 31 male, and their ages varied between 15 and 85 and the average age was 55.8±-17.3 years. In 50 patients, vitamin D deficiency was detected, and in 7 vitamin D deficiency was detected. The average level of vitamin D was 12.7 ± 5.0 ng/mL in male patients and 12.1 ± 7.3 ng/mL in female patients. There was no significant difference between the average levels of vitamin D in female and male patients (p>0.05). CONTRIBUTION and RESULTS: Our study found that both male and female patients with DVT had a low level of 25 (OH) D. This is also in line with some studies that define vitamin D deficiency as a risk factor for venous thrombosis. Furthermore, the combination of thrombophyllic risk factors and vitamin D deficiency is likely to increase the risk of DVT further.

Keywords: